Literature DB >> 12461330

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.

Cherie-Ann O Nathan1, Nazanin Amirghahri, Cliff Rice, Fleurette W Abreo, Runhua Shi, Fred J Stucker.   

Abstract

OBJECTIVES/HYPOTHESIS: Molecular analysis of surgical margins is playing an increasingly important role in establishing surgical margins. Most markers lack the sensitivity and ease of applicability for effective clinical use. To date, the proto-oncogene eIF4E (4E) is elevated in 100% of head and neck squamous cell carcinoma tumors and is of prognostic value in predicting recurrence. In a retrospective study, 4E overexpression in the margins appeared to be a more sensitive predictor of recurrence when compared with p53. The goal was to confirm this finding in a prospective study and also to compare the expression of matrix metalloproteinase-9 (MMP-9) to 4E expression in tumors and margins. Other objectives were to determine which of these markers have prognostic significance in predicting recurrence and elucidate whether there is any additional benefit to analysis of surgical margins with a combination of the three molecular markers. STUDY
DESIGN: A prospective study was performed on all patients who consecutively underwent primary surgical resection between 1998 and 1999 for head and neck squamous cell carcinoma. Patient and tumor characteristics were reviewed, and time to recurrence was noted.
METHODS: Paraffin-embedded sections of tumors and all histologically tumor-free margins were analyzed for the presence or absence of 4E, p53, and MMP-9 with immunohistochemical analysis. Patients were followed according to the institution's head and neck cancer protocol, and time to recurrence was noted.
RESULTS: Ninety-eight percent of tumors overexpressed 4E, 65% overexpressed p53, and 92% overexpressed MMP-9. Of the 52 patients with tumor-free margins, 52%, 46%, and 54% had positive margins for 4E, p53, and MMP-9, respectively. Although no significant correlation between 4E and p53 expression was seen in the margins (P =.16), a significant correlation between 4E and MMP-9 expression was noted (P =.0002). However, when expression of 4E and p53 in the margins of only the patients who overexpressed p53 in the tumors was compared (n = 34), there was a significant correlation (P =.04). There was also a significant difference in the disease-free interval between patients with 4E-positive and 4E-negative margins (P =.003). This difference in time to recurrence was not significant for the p53-positive versus the p53-negative group (P =.18) but approached significance when MMP-9 was used as a marker (P =.07). Although the univariate analysis showed that stage, nodal disease, grade, and 4E expression in the margins were significantly associated with disease-free interval, in the Cox multiple regression analysis, only 4E expression in the margin was significantly associated with disease-free interval (P =.01).
CONCLUSIONS: The era for molecular analysis of surgical margins is here. Although a significant correlation was seen between 4E and MMP-9, overexpression of 4E appears to be a significant predictor of recurrence when compared with the well-studied tumor suppressor gene p53 and a relatively novel marker, MMP-9.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461330     DOI: 10.1097/00005537-200212000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  28 in total

1.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

Review 2.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

Review 3.  Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology.

Authors:  Kristen D Herring; Stacey R Oppenheimer; Richard M Caprioli
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

Review 4.  Prevention of head and neck cancer.

Authors:  Terry A Day; Angela Chi; Brad Neville; James R Hebert
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

Review 5.  Dysregulated molecular networks in head and neck carcinogenesis.

Authors:  Alfredo A Molinolo; Panomwat Amornphimoltham; Cristiane H Squarize; Rogerio M Castilho; Vyomesh Patel; J Silvio Gutkind
Journal:  Oral Oncol       Date:  2008-09-19       Impact factor: 5.337

6.  A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

Authors:  Julie E Bauman; Hugo Arias-Pulido; Sang-Joon Lee; M Houman Fekrazad; Hiroyuki Ozawa; Elana Fertig; Jason Howard; Justin Bishop; Hao Wang; Garth T Olson; Michael J Spafford; Dennie V Jones; Christine H Chung
Journal:  Oral Oncol       Date:  2013-02-04       Impact factor: 5.337

7.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

Review 8.  Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges.

Authors:  Michelle D Williams
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

9.  Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.

Authors:  Heather E Kleiner; Prasad Krishnan; Jesse Tubbs; Mark Smith; Carol Meschonat; Runhua Shi; Mary Lowery-Nordberg; Patrick Adegboyega; Marcia Unger; James Cardelli; Quyen Chu; J Michael Mathis; John Clifford; Arrigo De Benedetti; Benjamin D L Li
Journal:  J Exp Clin Cancer Res       Date:  2009-01-09

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.